Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy.
Huizi ZhuLiang XuXiang LiuBing LiuChunjuan ZhaiRong WangXiaowei YangPublished in: Renal failure (2022)
Anti-PLA2R antibody was the independent risk factor for venous thrombosis in PMN. Larger prospective studies were warranted to verify the results in future.